What's new in infectious diseases

🦠 Infectious Disease Update (July 2025)

What's New?

Exciting developments in infectious diseases! 📢
A new vaccine formulation for RSV (Respiratory Syncytial Virus) is showing promise in protecting both infants and older adults. Also, recent research highlights a rise in antimicrobial resistance, reminding us of the urgent need for rational antibiotic use. Stay informed, stay protected! 💉🧬



Dr. Saido Ahmed

VIRAL INFECTIONS, NON-HIV

Palivizumab for prevention of hospitalization during the 2022-2023 RSV season (November 2022)

During the COVID-19 pandemic, interseasonal respiratory syncytial virus (RSV) activity increased in some regions, resulting in increased pediatric hospitalizations. In regions with interseasonal activity similar to that in a typical fall-winter season, expert groups supported administration of palivizumab to eligible children outside of the typically recommended schedule. If regional RSV activity persists at high levels through the fall and winter of the 2022-2023 RSV season, the American Academy of Pediatrics supports administration of more than five consecutive doses of palivizumab to eligible children who initiated palivizumab earlier than typically recommended.

Dr. Saido Ahmed